|
A study to evaluate the safety and efficacy of Kidney and liver transplants
in a select population of HIV infected individuals is currently in progress
at 17+ transplant centers across the country.
Must meet criteria for transplantation
• Must have T-cell count > 200 (kidney) or > 100 (liver)
• Must meet HIV viral load criteria depending on which organ needed
•
Patients with certain Opportunistic Infections in the past will be
considered
(T-Cell count must be above 200 if so)
Pediatric patients are being enrolled at several participating centers (see
below)
Specific Site & Study information can be found at:
http://spitfire.emmes.com/study/htrand
http://www.clinicaltrials.gov
Study Related Presentations & Published Literature can be found at:
http://spitfire.emmes.com.study/htr
/Useful_Links/useful_links.html
Participating Centers:
(visit the study website for updated list of centers
and contact information)
Atlanta Emory University (K)
Baltimore University of Maryland (K)
Boston Beth Israel Deaconess Medical Center (K, L)
Charlottesville University of Virginia (K, L)
Chicago University of Chicago (K, L, Peds K, Peds L)
Cincinnati University of Cincinnati
Los Angeles Cedars-Sinai
Miami University of Miami (K)
Minneapolis University of Minnesota (K, L)
New York Mount Sinai School of Medicine (K, L, Peds K)
New York Columbia University (L, Peds L)
Philadelphia Drexel University (K)
Philadelphia University of Pennsylvania (K, L)
Pittsburgh University of Pittsburgh (K, L)
San Francisco University of California (K, L, Peds K, Peds L)
Washington, D.C. Washington Hospital Center (K)
Washington, D.C. Georgetown Medical Center (K, L)
|
